Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.165 USD | -3.46% | -16.04% | -72.57% |
Apr. 30 | Canaccord Genuity Cuts Price Target on Annovis Bio to $26 From $36, Maintains Buy Rating | MT |
Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.57% | 58.91M | |
+4.20% | 106B | |
+6.93% | 23.47B | |
-14.37% | 21.9B | |
-6.50% | 18.77B | |
-38.55% | 17.85B | |
-7.62% | 16.78B | |
+7.07% | 14.41B | |
+39.13% | 12.86B | |
+324.96% | 8.78B |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- Brookline Capital Downgrades Annovis Bio to Hold From Buy, $9 Price Target